Oscar Health (OSCR) Stock Price, News & Analysis

Company Overview

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Key Stats

• Today's Range: $16.75 to $17.90
• 50-Day Range: $16.73 to $23.27
• 52-Week Range: $4.72 to $23.79
• Volume: 2.68 million shs
• Average Volume: 3.21 million shs
• Market Capitalization: $3.99 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $24.00
• Consensus Rating: Moderate Buy

Oscar Health Stock Analysis - MarketRank™

Oscar Health scored higher than 77% of companies evaluated by MarketBeat, and ranked 328th out of 911 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Oscar Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Oscar Health has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 5,600.00%

Earnings Growth

Earnings for Oscar Health are expected to grow by 5,600.00% in the coming year, from $0.01 to $0.57 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Oscar Health is -129.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Oscar Health is -129.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Oscar Health has a PEG Ratio of 36.01. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Oscar Health has a P/B Ratio of 4.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

6.94% of the float of Oscar Health has been sold short.

Short Interest Ratio / Days to Cover

Oscar Health has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Oscar Health has recently decreased by 5.28%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Oscar Health does not currently pay a dividend.

Dividend Growth

Oscar Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

6.94% of the float of Oscar Health has been sold short.

Short Interest Ratio / Days to Cover

Oscar Health has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Oscar Health has recently decreased by 5.28%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.59

News Sentiment

Oscar Health has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Oscar Health this week, compared to 5 articles on an average week.

Search Interest

Only 2 people have searched for OSCR on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.

MarketBeat Follows

8 people have added Oscar Health to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Oscar Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,007,069.00 in company stock.

Percentage Held by Insiders

25.11% of the stock of Oscar Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

75.70% of the stock of Oscar Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

OSCR Stock Analysis - Frequently Asked Questions

How have OSCR shares performed this year?

Oscar Health's stock was trading at $9.15 at the beginning of the year. Since then, OSCR stock has increased by 83.6% and is now trading at $16.80.
View the best growth stocks for 2024 here.

How were Oscar Health's earnings last quarter?

Oscar Health, Inc. (NYSE:OSCR) issued its quarterly earnings data on Wednesday, August, 7th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.04. The firm's quarterly revenue was up 44.6% compared to the same quarter last year.

When did Oscar Health IPO?

Oscar Health (OSCR) raised $1 billion in an initial public offering (IPO) on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse served as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Who are Oscar Health's major shareholders?

Oscar Health's top institutional shareholders include Gunderson Capital Management Inc. (0.10%), Udine Wealth Management Inc. (0.02%), SG Americas Securities LLC (0.02%) and Inspire Investing LLC (0.02%). Insiders that own company stock include Richard Scott Blackley, Alessandrea C Quane, Sid Sankaran, Ranmali Bopitiya, Victoria Baltrus, Steven Wolin, Mario Schlosser, Alphabet Inc, Dennis Weaver and Meghan V Joyce.
View institutional ownership trends.

How do I buy shares of Oscar Health?

Shares of OSCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Oscar Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oscar Health investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 10/17/2024
• Next Earnings (Confirmed): 11/07/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Hospital & medical service plans
• Sub-Industry: Insurance
• Current Symbol: NYSE:OSCR
• CUSIP: N/A
• CIK: 1568651
• Web: www.hioscar.com
• Phone: 646-403-3677
• Fax: N/A
• Employees: 2,400
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $24.00
• High Stock Price Target: $28.00
• Low Stock Price Target: $20.00
• Potential Upside/Downside: +42.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 8 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 1,680.00
• P/E Growth: 36.01
• Net Income: $-270,730,000.00
• Net Margins: 0.25%
• Pretax Margin: 0.33%
• Return on Equity: 1.86%
• Return on Assets: 0.44%

Debt

• Debt-to-Equity Ratio: 0.26
• Current Ratio: 0.91
• Quick Ratio: 0.91

Sales & Book Value

• Annual Sales: $7.23 billion
• Price / Sales: 0.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.51 per share
• Price / Book: 4.79

Miscellaneous

• Outstanding Shares: 237,224,000
• Free Float: 181,166,000
• Market Cap: $3.99 billion
• Optionable: Optionable
• Beta: 1.62